dc.contributor.author | Matur, Zeliha | |
dc.contributor.author | Atmaca, M.M. | |
dc.contributor.author | Durmus, H. | |
dc.contributor.author | Parman, Y. | |
dc.date.accessioned | 2015-01-23T13:49:09Z | |
dc.date.available | 2015-01-23T13:49:09Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Matur Z, Atmaca MM, Durmus H, Parman Y. Tafamidis treatment in a patient with transthyretin amyloidosis due to domino liver transplantation. Joint Congress of European Neurology, Istanbul, Turkey, May 2014. European Journal of Neurology. 2014; 21(Suppl 1): 453 | en_US |
dc.identifier.issn | 1351-5101 | |
dc.identifier.uri | https://hdl.handle.net/11446/680 | en_US |
dc.description | İstanbul Bilim Üniversitesi, Tıp Fakültesi. | en_US |
dc.description.abstract | Domino liver transplantation (DLT) increase the number of grafts available to treat patients with liver disease. But, this procedure has a risk of transmission of systemic transthyretin (TTR) amyloidosis. A 69-year-old FAP male patient whose complaints started 8 years after DLT was evaluated because of numbness and burning sensation of feet and hands, walking difficulty, dizziness, diarrhea, dry mouth, urinary retention. | en_US |
dc.description.uri | http://onlinelibrary.wiley.com/doi/10.1111/ene.12497/epdf | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Wiley-Blackwell | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.title | Tafamidis treatment in a patient with transthyretin amyloidosis due to domino liver transplantation | en_US |
dc.type | conferenceObject | en_US |
dc.relation.journal | European Journal of Neurology | en_US |
dc.department | DBÜ, Tıp Fakültesi | en_US |
dc.identifier.issue | Suppl. 1 | |
dc.identifier.volume | 21 | |
dc.identifier.startpage | 543 | |
dc.identifier.endpage | 543 | |
dc.contributor.authorID | TR118245 | en_US |
dc.contributor.authorID | TR125998 | en_US |
dc.contributor.authorID | TR126261 | en_US |
dc.relation.publicationcategory | Belirsiz | en_US |